BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33931789)

  • 1. [Screening for retinopathy of prematurity-the most important changes in the new German guidelines 2020].
    Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
    Ophthalmologe; 2021 Dec; 118(12):1240-1244. PubMed ID: 33931789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].
    Akman SH; Pfeil JM; Stahl A; Ehlers S; Böhne C; Bohnhorst B; Framme C; Brockmann D; Bajor A; Jacobsen C; Hufendiek K; Pielen A;
    Ophthalmologe; 2022 May; 119(5):497-505. PubMed ID: 34811591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.
    Ling KP; Liao PJ; Wang NK; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC; Wu WC
    Retina; 2020 Sep; 40(9):1793-1803. PubMed ID: 31800460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANALYSIS OF CHANGES IN CHARACTERISTICS OF SEVERE RETINOPATHY OF PREMATURITY PATIENTS AFTER SCREENING GUIDELINES WERE ISSUED IN CHINA.
    Chen Y; Feng J; Li F; Yin H; Liang J; Li X
    Retina; 2015 Aug; 35(8):1674-9. PubMed ID: 25719989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
    Gunay M; Sukgen EA; Celik G; Kocluk Y
    Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinopathy of Prematurity - Update on Classification, Screening, and Therapy].
    Li JQ; Kellner U; Lorenz B; Stahl A; Krohne TU
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):346-363. PubMed ID: 35253129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity.
    Hong GJ; Stinnett SS; Freedman SF; Wallace DK; Prakalapakorn SG
    J AAPOS; 2021 Jun; 25(3):177-180. PubMed ID: 33964453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
    Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
    Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for retinopathy of prematurity in Sweden 2008-2021: Reduced gestational age of treated infants and remaining differences in treatment type and recurrence rates between hospitals.
    Holmström G; Hellström A; Teär Fahnehjelm K; Gränse L; Sandgren Hochhard K; Sunnqvist B; Tornqvist K; Tsamadou D; Wallin A; Larsson E
    Acta Ophthalmol; 2024 Jun; 102(4):401-408. PubMed ID: 37698061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].
    Autrata R; Senková K; Holousová M; Krejcírová I; Dolezel Z; Borek I
    Cesk Slov Oftalmol; 2012 Feb; 68(1):29-36. PubMed ID: 22679695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review.
    Tan QQ; Christiansen SP; Wang J
    PLoS One; 2019; 14(12):e0225643. PubMed ID: 31790445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in treatment of retinopathy of prematurity in the Netherlands from 2010 to 2017.
    Trzcionkowska K; Vehmeijer WBHJ; Kerkhoff FT; Bauer NJC; Bennebroek CAM; Dijk PH; Dijkman KP; van den Dungen FAM; Eggink CA; Feenstra RPG; Groenendaal F; van Heijst AF; van der Hoeven MAHBM; Kornelisse RF; Kraal-Biezen E; Lopriore E; Onland W; Renardel de Lavalette VW; van Rijn LJ; Schuerman FABA; Simonsz HJ; Voskuil-Kerkhof ESM; Witlox RSGM; Termote JUM; Schalij-Delfos NE
    Acta Ophthalmol; 2021 Feb; 99(1):97-103. PubMed ID: 32701185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register.
    Holmström G; Hellström A; Gränse L; Saric M; Sunnqvist B; Wallin A; Tornqvist K; Larsson E
    Br J Ophthalmol; 2020 Jul; 104(7):943-949. PubMed ID: 31676594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
    Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA;
    JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY.
    Sancak S; Toptan HH; Gokmen Yildirim T; Karatekin G; Ovali F
    Retina; 2019 Apr; 39(4):706-711. PubMed ID: 29370028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening premature infants for retinopathy of prematurity in a tertiary hospital in Saudi Arabia.
    Mgharbil E; Raffa LH; Alessa S; Alamri A
    Ann Saudi Med; 2020; 40(2):87-93. PubMed ID: 32241163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.
    Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.